Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Htg Molecular Diagnostics Inc's Business Segments
Htg Molecular Diagnostics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 1
Regions Reported
-
Htg Molecular Diagnostics Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue by Product & Service Category - FY
- Product and product-related services48.7%
- Product-related services revenue37.6%
- RUO Sample processing37.6%
- Product revenue19.8%
- Instrument4%
- Consumables0%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product and product-related services | $ 1 | 48.7% |
| Product-related services revenue | $ 0 | 37.6% |
| RUO Sample processing | $ 0 | 37.6% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
3 more categories available
Sign in to unlock the full Htg Molecular Diagnostics Inc dataset.
Description of Htg Molecular Diagnostics Inc
HTG Molecular Diagnostics Inc is a biotechnology company that specializes in developing and commercializing molecular profiling and diagnostic platforms for clinical and research applications. The company's headquarters is located in Tucson, Arizona.
The primary focus of HTG Molecular Diagnostics is to empower precision medicine by offering solutions that enable the detection and measurement of RNA-centered biomarkers. The company has developed a proprietary technology called HTG EdgeSeq, which allows for the analysis of RNA samples in a highly efficient and cost-effective manner.
The HTG EdgeSeq technology utilizes next-generation sequencing (NGS) and extraction-free, multiplexed methods to provide accurate and reliable results. This technology allows researchers and clinicians to generate comprehensive molecular profiles of various diseases, including cancer, autoimmune disorders, and infectious diseases.
HTG Molecular Diagnostics' platforms are designed to streamline the entire molecular profiling process, from sample preparation to data analysis. The company offers a wide range of products and services, including customizable panels for targeted gene expression profiling, miRNA expression profiling, and immune response profiling. These panels can be used in research laboratories, clinical trials, and diagnostic settings.
One of the key advantages of HTG Molecular Diagnostics' platforms is their high throughput capabilities. The HTG EdgeSeq technology can process hundreds of samples simultaneously, which significantly reduces the time and cost associated with molecular profiling. This scalability makes it suitable for both small-scale and large-scale projects.
HTG Molecular Diagnostics has established partnerships with leading pharmaceutical companies, academic institutions, and clinical laboratories to further advance the development and adoption of its technology. These collaborations enable the company to expand its applications into new therapeutic areas and provide valuable insights for personalized medicine.
In addition to its diagnostic platforms, HTG Molecular Diagnostics also offers a range of services to support its customers. These services include assay development, protocol optimization, and data analysis. The company has a team of experienced scientists and bioinformatics experts who work closely with customers to ensure the successful implementation and utilization of its technology.
Overall, HTG Molecular Diagnostics Inc is a leading biotechnology company that is revolutionizing molecular profiling and diagnostic solutions. Through its innovative HTG EdgeSeq technology and collaborative approach, the company is making significant contributions to precision medicine and personalized healthcare.
The primary focus of HTG Molecular Diagnostics is to empower precision medicine by offering solutions that enable the detection and measurement of RNA-centered biomarkers. The company has developed a proprietary technology called HTG EdgeSeq, which allows for the analysis of RNA samples in a highly efficient and cost-effective manner.
The HTG EdgeSeq technology utilizes next-generation sequencing (NGS) and extraction-free, multiplexed methods to provide accurate and reliable results. This technology allows researchers and clinicians to generate comprehensive molecular profiles of various diseases, including cancer, autoimmune disorders, and infectious diseases.
HTG Molecular Diagnostics' platforms are designed to streamline the entire molecular profiling process, from sample preparation to data analysis. The company offers a wide range of products and services, including customizable panels for targeted gene expression profiling, miRNA expression profiling, and immune response profiling. These panels can be used in research laboratories, clinical trials, and diagnostic settings.
One of the key advantages of HTG Molecular Diagnostics' platforms is their high throughput capabilities. The HTG EdgeSeq technology can process hundreds of samples simultaneously, which significantly reduces the time and cost associated with molecular profiling. This scalability makes it suitable for both small-scale and large-scale projects.
HTG Molecular Diagnostics has established partnerships with leading pharmaceutical companies, academic institutions, and clinical laboratories to further advance the development and adoption of its technology. These collaborations enable the company to expand its applications into new therapeutic areas and provide valuable insights for personalized medicine.
In addition to its diagnostic platforms, HTG Molecular Diagnostics also offers a range of services to support its customers. These services include assay development, protocol optimization, and data analysis. The company has a team of experienced scientists and bioinformatics experts who work closely with customers to ensure the successful implementation and utilization of its technology.
Overall, HTG Molecular Diagnostics Inc is a leading biotechnology company that is revolutionizing molecular profiling and diagnostic solutions. Through its innovative HTG EdgeSeq technology and collaborative approach, the company is making significant contributions to precision medicine and personalized healthcare.
HTG Molecular Diagnostics, Inc. specializes in innovative molecular diagnostic solutions designed to advance precision medicine. The company focuses on providing products and services that enhance the understanding of complex diseases, particularly in oncology. Here’s a comprehensive breakdown of the segments, products, and services offered by HTG Molecular Diagnostics:
Segments
1. Clinical Diagnostics:
- HTG is heavily involved in clinical diagnostics, providing tools for molecular profiling of tumors. Their diagnostic tests are developed to aid clinicians in making informed treatment decisions for patients, primarily in the field of oncology.
2. Research:
- The company also caters to research institutions and laboratories that require advanced technologies for genomic analysis. The research segment focuses on enabling biomarker discovery, drug development, and clinical trials.
3. Pharmaceutical Services:
- HTG collaborates with pharmaceutical companies to provide profiling services that support drug development processes, particularly around targeted therapies. This segment emphasizes the importance of identifying suitable patient populations for clinical trials through advanced molecular analysis.
Products
1. HTG EdgeSeq Technology:
- This proprietary technology allows for simultaneous quantification of multiple RNA targets in a single analysis. It is designed for high-throughput applications and delivers accurate and reproducible results, which are crucial for research and clinical diagnostics.
2. RNA Analysis Kits:
- These kits are used to extract and analyze RNA from various biological samples, allowing researchers and clinicians to expedite their studies in gene expression profiling, immune profiling, and tumor microenvironment studies.
3. Pan-Cancer Panels:
- HTG offers panels that cover a wide range of cancers, helping in the identification of actionable biomarkers. These panels facilitate comprehensive profiling, aiding clinicians in selecting targeted therapies based on a patients specific cancer profile.
4. Customized Solutions:
- The company provides custom assay development services, enabling institutions to design and implement unique assays tailored to specific research needs or clinical applications.
5. HTG Transcriptome Panel:
- This product focuses on the analysis of thousands of transcripts simultaneously, helping to provide a broad view of the transcriptional landscape of tumors. It is essential for understanding the molecular underpinnings of cancer and other diseases.
Services
1. Laboratory Services:
- HTG Molecular Diagnostics operates CLIA-certified and CAP-accredited laboratories that perform tests using their proprietary platform. These laboratories offer comprehensive testing services that support oncology practices in diagnosing and managing cancer.
2. Bioinformatics Solutions:
- The company provides bioinformatics tools and analysis services that help researchers interpret the vast amounts of data generated from their molecular profiling technologies. These tools facilitate the integration of molecular data into actionable insights.
3. Training and Support:
- HTG offers training for laboratory personnel and clinicians on the application of their technologies, methodologies, and data interpretation. This educational support ensures that users can effectively utilize the company’s solutions.
4. Collaborative Research and Development:
- The company engages in partnerships with academic and commercial entities to develop new assays and technologies for the growing field of molecular diagnostics. This collaborative approach enhances innovation and expands the boundaries of current diagnostics.
Conclusion
HTG Molecular Diagnostics Inc. is deeply invested in bridging the gap between molecular diagnostics and clinical application, particularly in oncology. Through their comprehensive range of products and services, they strive to empower healthcare providers and researchers with the tools necessary to enhance patient care and encourage the advancement of precision medicine. Their integrated approach encompasses everything from advanced molecular technologies to comprehensive services that facilitate the implementation of these innovations in clinical and research settings.
Segments
1. Clinical Diagnostics:
- HTG is heavily involved in clinical diagnostics, providing tools for molecular profiling of tumors. Their diagnostic tests are developed to aid clinicians in making informed treatment decisions for patients, primarily in the field of oncology.
2. Research:
- The company also caters to research institutions and laboratories that require advanced technologies for genomic analysis. The research segment focuses on enabling biomarker discovery, drug development, and clinical trials.
3. Pharmaceutical Services:
- HTG collaborates with pharmaceutical companies to provide profiling services that support drug development processes, particularly around targeted therapies. This segment emphasizes the importance of identifying suitable patient populations for clinical trials through advanced molecular analysis.
Products
1. HTG EdgeSeq Technology:
- This proprietary technology allows for simultaneous quantification of multiple RNA targets in a single analysis. It is designed for high-throughput applications and delivers accurate and reproducible results, which are crucial for research and clinical diagnostics.
2. RNA Analysis Kits:
- These kits are used to extract and analyze RNA from various biological samples, allowing researchers and clinicians to expedite their studies in gene expression profiling, immune profiling, and tumor microenvironment studies.
3. Pan-Cancer Panels:
- HTG offers panels that cover a wide range of cancers, helping in the identification of actionable biomarkers. These panels facilitate comprehensive profiling, aiding clinicians in selecting targeted therapies based on a patients specific cancer profile.
4. Customized Solutions:
- The company provides custom assay development services, enabling institutions to design and implement unique assays tailored to specific research needs or clinical applications.
5. HTG Transcriptome Panel:
- This product focuses on the analysis of thousands of transcripts simultaneously, helping to provide a broad view of the transcriptional landscape of tumors. It is essential for understanding the molecular underpinnings of cancer and other diseases.
Services
1. Laboratory Services:
- HTG Molecular Diagnostics operates CLIA-certified and CAP-accredited laboratories that perform tests using their proprietary platform. These laboratories offer comprehensive testing services that support oncology practices in diagnosing and managing cancer.
2. Bioinformatics Solutions:
- The company provides bioinformatics tools and analysis services that help researchers interpret the vast amounts of data generated from their molecular profiling technologies. These tools facilitate the integration of molecular data into actionable insights.
3. Training and Support:
- HTG offers training for laboratory personnel and clinicians on the application of their technologies, methodologies, and data interpretation. This educational support ensures that users can effectively utilize the company’s solutions.
4. Collaborative Research and Development:
- The company engages in partnerships with academic and commercial entities to develop new assays and technologies for the growing field of molecular diagnostics. This collaborative approach enhances innovation and expands the boundaries of current diagnostics.
Conclusion
HTG Molecular Diagnostics Inc. is deeply invested in bridging the gap between molecular diagnostics and clinical application, particularly in oncology. Through their comprehensive range of products and services, they strive to empower healthcare providers and researchers with the tools necessary to enhance patient care and encourage the advancement of precision medicine. Their integrated approach encompasses everything from advanced molecular technologies to comprehensive services that facilitate the implementation of these innovations in clinical and research settings.